ERD

D3.2 Data analysis report and statistical power calculations

Project: SUPPORT-E

Updated at: 14-04-2024

Show more information

Project acronym SUPPORT-E

D6.5 Final Meeting-Stakeholder Conference

Project: SUPPORT-E

Updated at: 14-04-2024

Show more information

Project acronym SUPPORT-E

Periodic Reporting for period 3 - SUPPORT-E (SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOugho...

Project: SUPPORT-E

Updated at: 14-04-2024

Show more information

Project acronym SUPPORT-E

D7.4 Ethics review final report

Project: SUPPORT-E

Updated at: 28-03-2024

Show more information

Project acronym SUPPORT-E

D6.4 Technical report for laypersons

Project: SUPPORT-E

Updated at: 28-03-2024

Show more information

Project acronym SUPPORT-E

D5.3 Final Recommendations Report

Project: SUPPORT-E

Updated at: 28-03-2024

Show more information

Project acronym SUPPORT-E

D2.15 Status report: SUPPORT-E funding of clinical trials in need.

Project: SUPPORT-E

Updated at: 28-03-2024

Show more information

Project acronym SUPPORT-E

D6.6 Technical report for laypersons

Project: SUPPORT-E

Updated at: 28-03-2024

Show more information

Project acronym SUPPORT-E

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convale...

Project: SUPPORT-E

Updated at: 07-12-2023

Show more information

Project acronym SUPPORT-E

A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe...

Project: SUPPORT-E

Updated at: 07-12-2023

Show more information

Project acronym SUPPORT-E

Convalescent plasma for people with COVID-19: a living systematic review

Project: SUPPORT-E

Updated at: 07-12-2023

Show more information

Project acronym SUPPORT-E

Hyperimmune immunoglobulin for people with COVID‐19

Project: SUPPORT-E

Updated at: 07-12-2023

Show more information

Project acronym SUPPORT-E

D1.2 Preliminary guidance document with assessment criteria for clinical trials

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

A novel competition ELISA for the selection of COVID-19 convalescent plasma donors

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use...

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Eld...

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV...

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transpl...

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D1.5 Status report of international ongoing clinical trials

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D4.1 Variability between tests across Europe mapped so standardization and calibration possible

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D2.1 Status report: interactions with supported clinical trials and monitored access programmes

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

The need for and challenges of comparing SARS‐CoV‐2 antibody assays

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D4.3 PoC of test measuring in vitro virus neutralizing activity on ELISA basis

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D3.1 Dashboard report

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D2.3 Assessment report on data quality and number of complete datasets

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D3.5 Data Management status report

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D2.4 Status report: interactions with supported clinical trials and monitored access programmes

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D2.5 Status report: interactions with supported clinical trials and monitored access programmes

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D1.6 Status report of international ongoing clinical trials

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

D2.14 Analysis report on database data and novel generated data

Project: SUPPORT-E

Updated at: 30-11-2023

Show more information

Project acronym SUPPORT-E

Resources

Selected filters:

D3.2 Data analysis report and statistical power calculations

D6.5 Final Meeting-Stakeholder Conference

Periodic Reporting for period 3 - SUPPORT-E (SUPporting high quality evaluation of COVID-19 convalescent Plasma thrOugho...

D7.4 Ethics review final report

D6.4 Technical report for laypersons

D5.3 Final Recommendations Report

D2.15 Status report: SUPPORT-E funding of clinical trials in need.

D6.6 Technical report for laypersons

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convale...

A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe...

Convalescent plasma for people with COVID-19: a living systematic review

Hyperimmune immunoglobulin for people with COVID‐19

D1.2 Preliminary guidance document with assessment criteria for clinical trials

A novel competition ELISA for the selection of COVID-19 convalescent plasma donors

SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use...

BNT162b2 Vaccination Elicits Strong Serological Immune Responses Against SARS-CoV-2 Including Variants of Concern in Eld...

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV...

Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transpl...

D1.5 Status report of international ongoing clinical trials

D4.1 Variability between tests across Europe mapped so standardization and calibration possible

D2.1 Status report: interactions with supported clinical trials and monitored access programmes

The need for and challenges of comparing SARS‐CoV‐2 antibody assays

D4.3 PoC of test measuring in vitro virus neutralizing activity on ELISA basis

D3.1 Dashboard report

D2.3 Assessment report on data quality and number of complete datasets

D3.5 Data Management status report

D2.4 Status report: interactions with supported clinical trials and monitored access programmes

D2.5 Status report: interactions with supported clinical trials and monitored access programmes

D1.6 Status report of international ongoing clinical trials

D2.14 Analysis report on database data and novel generated data